Transgenic algae for delivering antigens to an animal
AssigneesPhyterra Bio Inc., The Ohio State University
InventorsRichard T. Sayre, Richard E. Wagner, Surasak Siripornadulsil, Carlos Farias
Life of this patent
Estimating the term…
Loading patent…
AssigneesPhyterra Bio Inc., The Ohio State University
InventorsRichard T. Sayre, Richard E. Wagner, Surasak Siripornadulsil, Carlos Farias
Estimating the term…
Delivery systems and methods are provided for delivering a biologically active protein to a host animal. The systems and methods provided include obtaining an algal cell transformed by an expression vector, the expression vector comprising a nucleotide sequence coding for the biologically active protein, operably linked to a promoter. In one illustrated embodiment, the biologically active protein is an antigenic epitope and upon administration to the animal the algal cell induces an immune response in the host animal.
A method for delivering antigens to a host animal to induce an immune response in the host animal, the method comprising the steps of
Dependencies are inferred from the claim text.
Drawings are temporarily unavailable. Open the PDF at USPTO
From the US filing history. Foreign family members aren’t listed.
Bacterial antigens: specific bacteria not otherwise provided for
Obtained by microbiological or biochemical processes: addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff…
Amino acids; Derivatives thereof: polymeric derivatives, e.g. peptides or proteins
Feeding-stuffs specially adapted for particular animals
Term ended 30 Jan 2026 (estimated)
This invention relates to a system for delivering antigens to an animal.
Proteins, dipeptide and polypeptide (hereinafter collectively referred to as proteins) are responsible for most of the activities of a cell, such as catalysis, communication, defense, movement, and transport.
Proteins can be delivered to animals for the purpose of activating or supplementing a biological activity. Examples include antigens that activate an immune response and hormones that regulate growth and development.
The present invention may be more readily understood by reference to the following figures wherein:
FIG. 1 shows the pSSCR7 plasmid used for constructing nuclear transfection vectors for use in the present invention;
FIG. 2 shows the pCPPTG plasmid used for constructing chloroplast transfection vectors for use in the present invention;
In one aspect of the present invention provides a delivery system for introducing one or more peptides into a host animal. The delivery system involves the use of is a transgenic algae comprising a transgene which comprises a polynucleotide encoding one or more peptides and a promoter which drives expression of the peptide encoding sequence in the algae.
Antigenic Determinant
The term “antigenic determinant” as used herein refers to a protein or polypeptide which is capable of eliciting an immune response or defense response in the host animal. The antigenic determinant is at least partially derived from a pathogenic microorganism. Herein, the term “microorganism” means a bacterium, virus, fungus, or parasite (i.e., protozoan or helminth, for example). Preferably, the immune response or defense response elicited by the antigenic determinant is protective in the host animal in the sense that a subsequent infection of the host animal by the pathogenic organism from which the antigenic determinant is derived would be prevented, would not cause disease or, if disease were caused, the disease or symptoms associated with the disease would be ameliorated. Preferably, the antigenic determinant itself does not cause disease or any other adverse symptoms in the host animal.